Prenetics
2014
FOUNDED
PRIVATE
STATUS
91-100
EMPLOYEES
Series B
LATEST DEAL TYPE
$40M
LATEST DEAL AMOUNT
14
INVESTORS
Description
Developer of a pharmacogenomics platform designed to offer personalized, predictive and preventive treatments. The company's pharmacogenomics platform offers a health-coaching application that provides individuals with a DNA profile in order to facilitate optimal diet, fitness and response to drugs and enables them to understand their genetic risk of common health conditions such as Type 2 Diabetes, High Blood Pressure and High Cholesterol, enabling physicians to help patients identify the right drug, right dosage and to list out potential adverse drug effects (ADEs), based on one's genetic profile platform.
Website
Formerly Known As
Multigene
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Other Healthcare Services
Primary Office
- 7/F, Prosperity Millennia Plaza
- 663 King's Road
- Quarry Bay
- Hong Kong
+852 2210 0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Prenetics’s full profile, request a free trial.
Prenetics Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC (Series B) | 18-Oct-2017 | $40M | 000.00 | Completed | Generating Revenue | |
| 3. Later Stage VC (Series A) | 16-Mar-2016 | 0000 | 000.00 | Completed | Startup | |
| 2. Later Stage VC | 01-Nov-2015 | $2.65M | Completed | Startup | ||
| 1. Seed Round | 03-Dec-2014 | $2.65M | $2.65M | Completed | Startup |
Prenetics Competitors (6)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Genomic Expression | Venture Capital-Backed | New York, NY | 0 | 00000 | 0000000000 | 00000 |
| 00000 00000000 | Private Equity-Backed | Aliso Viejo, CA | 000 | 00000 | 000000&0 | 00000 |
| 0000000 | Venture Capital-Backed | Mountain View, CA | 000 | 00000 | 00000000000 | 00000 |
| 0000000000 | Private Equity-Backed | Princeton, NJ | 0000 | 000.00 | 000000000000 | 000.00 |
| 000000000 00000000 | Venture Capital-Backed | Helsinki, Finland | 000 | 000.00 | 00000 00000 |
Prenetics Investments & Acquisitions (3)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 0000 000000000 | 29-Jan-2019 | 000000000000000000 | Application Software | 000 0000000 | |
| 00000000 00000000 | 08-Nov-2018 | 00000 0000000 | Biotechnology | 00000 00000 | |
| DNAFit Life Sciences | 17-Apr-2018 | Merger/Acquisition | 0000 | Biotechnology | 00000 00000 |
Prenetics Subsidiaries (2)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| DNAFit Life Sciences | Biotechnology | London, United Kingdom | 2013 |
| 0000 000000000 | Application Software | London, United Kingdom | 0000 |
Prenetics Investors (14)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Alibaba Entrepreneurs Fund | Corporate Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Beyond Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| eGarden Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| MFund | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Yuantai Investment Partners | PE/Buyout | Minority | 000 0000 | 000000 0 |